Microorganisms and methods for the biosynthesis of adipate, hexamethylenediamine and 6-aminocaproic acid
US-2017218414-A1 · Aug 3, 2017 · US
US10415042B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-10415042-B2 |
| Application number | US-201615184940-A |
| Country | US |
| Kind code | B2 |
| Filing date | Jun 16, 2016 |
| Priority date | Mar 27, 2008 |
| Publication date | Sep 17, 2019 |
| Grant date | Sep 17, 2019 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
The invention provides a non-naturally occurring microbial organism having an adipate, 6-aminocaproic acid or caprolactam pathway. The microbial organism contains at least one exogenous nucleic acid encoding an enzyme in the respective adipate, 6-aminocaproic acid or caprolactam pathway. The invention additionally provides a method for producing adipate, 6-aminocaproic acid or caprolactam. The method can include culturing an adipate, 6-aminocaproic acid or caprolactam producing microbial organism, where the microbial organism expresses at least one exogenous nucleic acid encoding an adipate, 6-aminocaproic acid or caprolactam pathway enzyme in a sufficient amount to produce the respective product, under conditions and for a sufficient period of time to produce adipate, 6-aminocaproic acid or caprolactam.
Opening claim text (preview).
What is claimed is: 1. A non-naturally occurring microbial organism having a 6-aminocaproic acid pathway and an adipyl-CoA pathway, wherein said 6-aminocaproic acid pathway comprises at least one exogenous nucleic acid encoding a 6-aminocaproic acid pathway enzyme expressed in a sufficient amount to produce 6-aminocaproic acid, wherein said 6-aminocaproic acid pathway comprises a CoA-dependent aldehyde dehydrogenase; and a transaminase or a 6-aminocaproate dehydrogenase, wherein said transaminase converts adipate semialdehyde to 6-aminocaproic acid, wherein said adipyl-CoA pathway comprises at least one exogenous nucleic acid encoding an adipyl-CoA pathway enzyme expressed in a sufficient amount to produce adipyl-CoA, and wherein said adipyl-CoA pathway comprises alpha-ketoadipyl-CoA synthetase, phosphotransketoadipylase/alpha-ketoadipate kinase or alpha-ketoadipyl-CoA:acetyl-CoA transferase; 2-hydroxyadipyl-CoA dehydrogenase; 2-hydroxyadipyl-CoA dehydratase; and a 5-carboxy-2-pentenoyl-CoA reductase. 2. The non-naturally occurring microbial organism of claim 1 , wherein said microbial organism comprises one or two exogenous nucleic acids each encoding a 6-aminocaproic acid pathway enzyme. 3. The non-naturally occurring microbial organism of claim 1 , wherein the microbial organism further has a caprolactam pathway comprising at least one exogenous nucleic acid encoding a caprolactam pathway enzyme expressed in a sufficient amount to produce caprolactam, said caprolactam pathway comprising an amidohydrolase. 4. The non-naturally occurring microbial organism of claim 1 , wherein said microbial organism comprises one, two, three, or four exogenous nucleic acids each encoding an adipyl-CoA pathway enzyme. 5. The non-naturally occurring microbial organism of claim 1 , wherein said at least one exogenous nucleic acid is a heterologous nucleic acid. 6. The non-naturally occurring microbial organism of claim 1 , wherein said microbial organism is a species of bacteria, yeast, or fungus. 7. The non-naturally occurring microbial organism of claim 1 , wherein the microbial organism is a species of bacteria selected from the group consisting of Escherichia coli, Klebsiella oxytoca, Anaerobiospirillum succiniciproducens, Actinobacillus succinogenes, Mannheimia succiniciproducens, Rhizobium etli, Bacillus subtilis, Corynebacterium glutamicum, Gluconobacter oxydans, Zymomonas mobilis, Lactococcus lactis, Lactobacillus plantarum, Streptomyces coelicolor, Clostridium acetobutylicum, Pseudomonas fluorescens , and Pseudomonas putida. 8. The non-naturally occurring microbial organism of claim 1 , wherein the microbial organism is a species of yeast or fungus selected from the group consisting of Saccharomyces cerevisiae, Schizosaccharomyces pombe, Kluyveromyces lactis, Kluyveromyces marxianus, Aspergillus terreus, Aspergillus niger and Pichia pastoris. 9. The non-naturally occurring microbial organism of claim 8 , wherein the microbial organism is a species of Saccharomyces cerevisiae. 10. A method for producing 6-aminocaproic acid, comprising culturing the non-naturally occurring microbial organism of claim 1 under conditions and for a sufficient period of time to produce 6-aminocaproic acid. 11. The method of claim 10 , wherein said non-naturally occurring microbial organism is in a substantially anaerobic culture medium. 12. The method of claim 10 , wherein said method further comprises separating the 6-aminocaproic acid from other components in the culture. 13. The method of claim 12 , wherein the separating comprises extraction, continuous liquid-liquid extraction, pervaporation, membrane filtration, membrane separation, reverse osmosis, electrodialysis, distillation, crystallization, centrifugation, extractive filtration, ion exchange chromatography, size exclusion chromatography, absorption chromatography, or ultrafiltration. 14. A method for producing caprolactam, comprising culturing the non-naturally occurring microbial organism of claim 3 under conditions and for a sufficient period of time to produce caprolactam. 15. The method of claim 14 , wherein said non-naturally occurring microbial organism is in a substantially anaerobic culture medium. 16. The method of claim 14 , wherein said method further comprises separating the caprolactam from other components in the culture. 17. The method of claim 14 , wherein the separating comprises extraction, continuous liquid-liquid extraction, pervaporation, membrane filtration, membrane separation, reverse osmosis, electrodialysis, distillation, crystallization, centrifugation, extractive filtration, ion exchange chromatography, size exclusion chromatography, absorption chromatography, or ultrafiltration.
Transaminases (2.6.1) · CPC title
Polycarboxylic acids · CPC title
Acetaldehyde dehydrogenase (acetylating) (1.2.1.10) · CPC title
Lyases (4.) · CPC title
acting on amide bonds in linear amides {(3.5.1)} · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.